Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT

OBJECTIVE: To assess long-term (2 years) effects of bimagrumab in participants with sporadic inclusion body myositis (sIBM). METHODS: Participants (aged 36–85 years) who completed the core study (RESILIENT [Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, M...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neurology
Main Authors: Amato, Anthony A., Hanna, Michael G., Machado, Pedro M., Badrising, Umesh A., Chinoy, Hector, Benveniste, Olivier, Karanam, Ananda Krishna, Wu, Min, Tankó, László B., Schubert-Tennigkeit, Agnes Annette, Papanicolaou, Dimitris A., Lloyd, Thomas E., Needham, Merrilee, Liang, Christina, Reardon, Katrina A., de Visser, Marianne, Ascherman, Dana P., Barohn, Richard J., Dimachkie, Mazen M., Miller, James A.L., Kissel, John T., Oskarsson, Björn, Joyce, Nanette C., Van den Bergh, Peter, Baets, Jonathan, De Bleecker, Jan L., Karam, Chafic, David, William S., Mirabella, Massimiliano, Nations, Sharon P., Jung, Hans H., Pegoraro, Elena, Maggi, Lorenzo, Rodolico, Carmelo, Filosto, Massimiliano, Shaibani, Aziz I., Sivakumar, Kumaraswamy, Goyal, Namita A., Mori-Yoshimura, Madoka, Yamashita, Satoshi, Suzuki, Naoki, Aoki, Masashi, Katsuno, Masahisa, Morihata, Hirokazu, Murata, Kenya, Nodera, Hiroyuki, Nishino, Ichizo, Romano, Carla D., Williams, Valerie S.L., Vissing, John, Zhang Auberson, Lixin
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8032371/
https://ncbi.nlm.nih.gov/pubmed/33597289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000011626
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados